US Stock MarketDetailed Quotes

ZOM Zomedica

Watchlist

0.1324
+0.0029+2.24%

Trading Nov 25 11:22 ET

129.75MMarket Cap-2036P/E (TTM)

Zomedica Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-58.44%-4.8M

-82.78%-6.72M

-78.29%-7.59M

-36.89%-15.98M

-110.45%-5.02M

-9.28%-3.03M

9.14%-3.68M

-72.28%-4.26M

18.25%-11.67M

51.40%-2.38M

Net income from continuing operations

-1,269.53%-6.7M

-355.92%-23.93M

-43.46%-9.16M

-102.93%-34.53M

-697.65%-22.41M

90.21%-489K

0.46%-5.25M

-62.18%-6.39M

7.45%-17.02M

14.65%-2.81M

Operating gains losses

1,438.46%174K

--112K

---12K

-2,300.00%-24K

36.36%-7K

-244.44%-13K

----

99.65%-1K

-120.00%-11K

Depreciation and amortization

27.07%2.03M

34.58%1.98M

41.67%1.93M

55.81%6.3M

51.79%1.87M

38.30%1.6M

75.51%1.47M

66.42%1.36M

254.87%4.04M

48.79%1.23M

Deferred tax

---65K

---195K

---184K

41.38%-1.49M

--471K

----

--0

---2.54M

----

Other non cash items

----

300.00%2K

-12,518.75%-1.99M

--187K

----

---1K

-57.89%16K

----

Change In working capital

82.04%-213K

3.02%-994K

-110.14%-725K

100.60%19K

225.95%2.58M

-165.32%-1.19M

51.47%-1.03M

75.25%-345K

18.40%-3.16M

115.72%790K

-Change in receivables

57.11%-217K

179.78%355K

-131.94%-130K

56.40%-269K

212.70%275K

-24.02%-506K

-611.49%-445K

882.69%407K

-191.04%-617K

-197.56%-244K

-Change in inventory

-103.79%-8K

14.22%-712K

108.21%60K

73.58%-1.06M

178.44%291K

119.81%211K

47.03%-830K

27.26%-731K

-44.48%-4.01M

58.73%-371K

-Change in prepaid assets

-247.34%-470K

-133.36%-440K

144.03%450K

202.32%1.5M

754.07%883K

134.67%319K

345.17%1.32M

-898.44%-1.02M

-1,026.92%-1.47M

-95.65%-135K

-Change in payables and accrued expense

180.39%410K

100.93%13K

-247.59%-1.13M

-92.38%259K

141.90%1.4M

-118.70%-510K

-698.72%-1.4M

643.97%767K

111.50%3.4M

136.07%580K

-Change in other current liabilities

110.59%72K

-177.32%-225K

-85.59%17K

-3.10%-731K

10.33%-460K

-195.65%-680K

561.36%291K

1,280.00%118K

-560.39%-709K

-433.12%-513K

-Change in other working capital

--0

-63.41%15K

-91.38%10K

36.17%320K

-87.58%183K

96.38%-20K

111.02%41K

136.94%116K

109.32%235K

--1.47M

Cash from discontinued investing activities

Operating cash flow

-58.44%-4.8M

-82.78%-6.72M

-78.29%-7.59M

-36.89%-15.98M

-110.45%-5.02M

-9.28%-3.03M

9.14%-3.68M

-72.28%-4.26M

18.25%-11.67M

51.40%-2.38M

Investing cash flow

Cash flow from continuing investing activities

309.45%6.54M

-83.83%3.77M

138.03%5.63M

101.01%1.58M

75.06%-3.83M

97.75%-3.12M

1,722.89%23.32M

-7,080.58%-14.79M

-116.73%-155.88M

78.55%-15.35M

Net PPE purchase and sale

83.34%-1.08M

34.30%-1.22M

-140.72%-2.34M

36.98%-496K

723.18%8.81M

-433.03%-6.47M

-326.32%-1.86M

-370.87%-970K

-435.37%-787K

2,240.00%1.07M

Net intangibles purchase and sale

83.33%-9K

36.36%-42K

99.30%-28K

-1,636.40%-4.15M

68.75%-30K

62.24%-54K

---66K

---4M

36.94%-239K

27.82%-96K

Net business purchase and sale

--0

----

1.42%-23.96M

---11.3M

---12.66M

----

65.96%-24.3M

--0

Net investment purchase and sale

-52.51%7.63M

-78.32%5.48M

181.33%7.99M

123.12%30.18M

91.99%-1.31M

114.19%16.06M

2,625.00%25.25M

---9.82M

---130.55M

---16.33M

Cash from discontinued investing activities

Investing cash flow

309.45%6.54M

-83.83%3.77M

138.03%5.63M

101.01%1.58M

75.06%-3.83M

97.75%-3.12M

1,722.89%23.32M

-7,080.58%-14.79M

-116.73%-155.88M

78.55%-15.35M

Financing cash flow

Cash flow from continuing financing activities

-100.00%8K

Proceeds from stock option exercised by employees

----

--0

----

-99.98%8K

--0

Cash from discontinued financing activities

Financing cash flow

----

--0

----

-100.00%8K

--0

Net cash flow

Beginning cash position

-71.60%7.94M

30.96%10.94M

-52.73%12.95M

-85.95%27.4M

-51.70%21.78M

-85.03%27.95M

-95.66%8.35M

-85.95%27.4M

214.48%194.95M

-83.39%45.1M

Current changes in cash

127.24%1.68M

-115.00%-2.95M

89.68%-1.97M

91.41%-14.4M

50.13%-8.84M

95.66%-6.15M

458.29%19.65M

-611.58%-19.05M

-226.01%-167.54M

76.81%-17.73M

Effect of exchange rate changes

838.89%133K

-12.77%-53K

-1,700.00%-48K

-345.45%-49K

-65.79%13K

10.00%-18K

48.35%-47K

-95.16%3K

-650.00%-11K

1,800.00%38K

End cash Position

-55.25%9.75M

-71.60%7.94M

30.96%10.94M

-52.73%12.95M

-51.70%21.78M

-85.03%27.95M

-95.66%8.35M

-85.95%27.4M

Free cash flow

38.41%-5.88M

-42.46%-7.99M

-7.87%-9.95M

-62.42%-20.62M

367.07%3.76M

-131.45%-9.55M

-25.03%-5.61M

-244.68%-9.23M

14.23%-12.7M

72.30%-1.41M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-58.44%-4.8M	-82.78%-6.72M	-78.29%-7.59M	-36.89%-15.98M	-110.45%-5.02M	-9.28%-3.03M	9.14%-3.68M	-72.28%-4.26M	18.25%-11.67M	51.40%-2.38M
Net income from continuing operations	-1,269.53%-6.7M	-355.92%-23.93M	-43.46%-9.16M	-102.93%-34.53M	-697.65%-22.41M	90.21%-489K	0.46%-5.25M	-62.18%-6.39M	7.45%-17.02M	14.65%-2.81M
Operating gains losses	1,438.46%174K	--112K	---12K	-2,300.00%-24K	36.36%-7K	-244.44%-13K	----	----	99.65%-1K	-120.00%-11K
Depreciation and amortization	27.07%2.03M	34.58%1.98M	41.67%1.93M	55.81%6.3M	51.79%1.87M	38.30%1.6M	75.51%1.47M	66.42%1.36M	254.87%4.04M	48.79%1.23M
Deferred tax	---65K	---195K	---184K	41.38%-1.49M	--471K	----	----	--0	---2.54M	----
Other non cash items	----	----	300.00%2K	-12,518.75%-1.99M	--187K	----	----	---1K	-57.89%16K	----
Change In working capital	82.04%-213K	3.02%-994K	-110.14%-725K	100.60%19K	225.95%2.58M	-165.32%-1.19M	51.47%-1.03M	75.25%-345K	18.40%-3.16M	115.72%790K
-Change in receivables	57.11%-217K	179.78%355K	-131.94%-130K	56.40%-269K	212.70%275K	-24.02%-506K	-611.49%-445K	882.69%407K	-191.04%-617K	-197.56%-244K
-Change in inventory	-103.79%-8K	14.22%-712K	108.21%60K	73.58%-1.06M	178.44%291K	119.81%211K	47.03%-830K	27.26%-731K	-44.48%-4.01M	58.73%-371K
-Change in prepaid assets	-247.34%-470K	-133.36%-440K	144.03%450K	202.32%1.5M	754.07%883K	134.67%319K	345.17%1.32M	-898.44%-1.02M	-1,026.92%-1.47M	-95.65%-135K
-Change in payables and accrued expense	180.39%410K	100.93%13K	-247.59%-1.13M	-92.38%259K	141.90%1.4M	-118.70%-510K	-698.72%-1.4M	643.97%767K	111.50%3.4M	136.07%580K
-Change in other current liabilities	110.59%72K	-177.32%-225K	-85.59%17K	-3.10%-731K	10.33%-460K	-195.65%-680K	561.36%291K	1,280.00%118K	-560.39%-709K	-433.12%-513K
-Change in other working capital	--0	-63.41%15K	-91.38%10K	36.17%320K	-87.58%183K	96.38%-20K	111.02%41K	136.94%116K	109.32%235K	--1.47M
Cash from discontinued investing activities
Operating cash flow	-58.44%-4.8M	-82.78%-6.72M	-78.29%-7.59M	-36.89%-15.98M	-110.45%-5.02M	-9.28%-3.03M	9.14%-3.68M	-72.28%-4.26M	18.25%-11.67M	51.40%-2.38M
Investing cash flow
Cash flow from continuing investing activities	309.45%6.54M	-83.83%3.77M	138.03%5.63M	101.01%1.58M	75.06%-3.83M	97.75%-3.12M	1,722.89%23.32M	-7,080.58%-14.79M	-116.73%-155.88M	78.55%-15.35M
Net PPE purchase and sale	83.34%-1.08M	34.30%-1.22M	-140.72%-2.34M	36.98%-496K	723.18%8.81M	-433.03%-6.47M	-326.32%-1.86M	-370.87%-970K	-435.37%-787K	2,240.00%1.07M
Net intangibles purchase and sale	83.33%-9K	36.36%-42K	99.30%-28K	-1,636.40%-4.15M	68.75%-30K	62.24%-54K	---66K	---4M	36.94%-239K	27.82%-96K
Net business purchase and sale	--0	----	----	1.42%-23.96M	---11.3M	---12.66M	----	----	65.96%-24.3M	--0
Net investment purchase and sale	-52.51%7.63M	-78.32%5.48M	181.33%7.99M	123.12%30.18M	91.99%-1.31M	114.19%16.06M	2,625.00%25.25M	---9.82M	---130.55M	---16.33M
Cash from discontinued investing activities
Investing cash flow	309.45%6.54M	-83.83%3.77M	138.03%5.63M	101.01%1.58M	75.06%-3.83M	97.75%-3.12M	1,722.89%23.32M	-7,080.58%-14.79M	-116.73%-155.88M	78.55%-15.35M
Financing cash flow
Cash flow from continuing financing activities				0	0				-100.00%8K	0
Proceeds from stock option exercised by employees	----	----	----	--0	----	----	----	----	-99.98%8K	--0
Cash from discontinued financing activities
Financing cash flow	----	----	----	--0	--0	----	----	----	-100.00%8K	--0
Net cash flow
Beginning cash position	-71.60%7.94M	30.96%10.94M	-52.73%12.95M	-85.95%27.4M	-51.70%21.78M	-85.03%27.95M	-95.66%8.35M	-85.95%27.4M	214.48%194.95M	-83.39%45.1M
Current changes in cash	127.24%1.68M	-115.00%-2.95M	89.68%-1.97M	91.41%-14.4M	50.13%-8.84M	95.66%-6.15M	458.29%19.65M	-611.58%-19.05M	-226.01%-167.54M	76.81%-17.73M
Effect of exchange rate changes	838.89%133K	-12.77%-53K	-1,700.00%-48K	-345.45%-49K	-65.79%13K	10.00%-18K	48.35%-47K	-95.16%3K	-650.00%-11K	1,800.00%38K
End cash Position	-55.25%9.75M	-71.60%7.94M	30.96%10.94M	-52.73%12.95M	-52.73%12.95M	-51.70%21.78M	-85.03%27.95M	-95.66%8.35M	-85.95%27.4M	-85.95%27.4M
Free cash flow	38.41%-5.88M	-42.46%-7.99M	-7.87%-9.95M	-62.42%-20.62M	367.07%3.76M	-131.45%-9.55M	-25.03%-5.61M	-244.68%-9.23M	14.23%-12.7M	72.30%-1.41M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data